Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Spero Therapeutics Inc
SWB:2HA
Spero Therapeutics Inc
SWB:2HA
Price:
32.762
EUR
-0.01%
Market Closed
Market Cap:
€1.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Spero Therapeutics Inc
SWB:2HA
|
US |
|
River City Bank
NASDAQ:RCBC
|
US |
|
Yamato Holdings Co Ltd
OTC:YATRF
|
JP |
|
O
|
Odakyu Electric Railway Co Ltd
DUS:V8H
|
JP |
|
G
|
Givaudan SA
SWB:GIN
|
CH |
|
Mirarth Holdings Inc
OTC:TKLLF
|
JP |
Wall St Price Targets
2HA Price Forecast
Based on 4 analysts
Based on 4 analysts
-83% Downside
from
€32.762
today
Spero Therapeutics Inc (2HA)’s 12-month stock price forecast through December 2016 has a consensus target of €5.491, implying 83% downside. The forecast is based on price targets from 4 Wall Street analysts.
2HA Analyst Rating
No ratings yet
No ratings yet
Spero Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2HA's stock price target?
Price Target
5.491
EUR
5.491
EUR
According to Wall Street analysts, the average 1-year price target for 2HA is 5.491 EUR with a low forecast of 3.625 EUR and a high forecast of 5.652 EUR.
What is the Revenue forecast for Spero Therapeutics Inc?
Projected CAGR
-20%
-20%
Over the last 9 years, the compound annual growth rate for Revenue has been 80%. The projected CAGR for the next 3 years is -20%.
